Literature DB >> 21325597

Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

Janos Sumegi1, Michael G Barnes, Shawnagay V Nestheide, Susan Molleran-Lee, Joyce Villanueva, Kejian Zhang, Kimberly A Risma, Alexei A Grom, Alexandra H Filipovich.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is a rare, genetically heterogeneous autosomal recessive immune disorder that results when the critical regulatory pathways that mediate immune defense mechanisms and the natural termination of immune/inflammatory responses are disrupted or overwhelmed. To advance the understanding of FHL, we performed gene expression profiling of peripheral blood mononuclear cells from 11 children with untreated FHL. Total RNA was isolated and gene expression levels were determined using microarray analysis. Comparisons between patients with FHL and normal pediatric controls (n = 30) identified 915 down-regulated and 550 up-regulated genes with more than or equal to 2.5-fold difference in expression (P ≤ .05). The expression of genes associated with natural killer cell functions, innate and adaptive immune responses, proapoptotic proteins, and B- and T-cell differentiation were down-regulated in patients with FHL. Genes associated with the canonical pathways of interleukin-6 (IL-6), IL-10 IL-1, IL-8, TREM1, LXR/RXR activation, and PPAR signaling and genes encoding of antiapoptotic proteins were overexpressed in patients with FHL. This first study of genome-wide expression profiling in children with FHL demonstrates the complexity of gene expression patterns, which underlie the immunobiology of FHL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325597      PMCID: PMC3087540          DOI: 10.1182/blood-2010-08-300046

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?

Authors:  Alexei A Grom
Journal:  Arthritis Rheum       Date:  2004-03

2.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.

Authors:  J I Henter; G Elinder; A Ost
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

Review 3.  ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery.

Authors:  N Isakov
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; L Nespoli; R Maccario; D Montagna; F Bonetti; D Caselli; G R Burgio
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

5.  Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis.

Authors:  Y Osugi; J Hara; S Tagawa; K Takai; G Hosoi; Y Matsuda; H Ohta; H Fujisaki; M Kobayashi; N Sakata; K Kawa-Ha; S Okada; A Tawa
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

6.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

Review 7.  A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Authors:  Wim Vanden Berghe; Linda Vermeulen; Philippe Delerive; Karolien De Bosscher; Bart Staels; Guy Haegeman
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

8.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

9.  Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3).

Authors:  Jérôme Feldmann; Isabelle Callebaut; Graça Raposo; Stéphanie Certain; Delphine Bacq; Cécile Dumont; Nathalie Lambert; Marie Ouachée-Chardin; Gaëlle Chedeville; Hannah Tamary; Véronique Minard-Colin; Etienne Vilmer; Stéphane Blanche; Françoise Le Deist; Alain Fischer; Geneviève de Saint Basile
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

Review 10.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  41 in total

1.  IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.

Authors:  Stéphanie Humblet-Baron; Dean Franckaert; James Dooley; Fatima Ailal; Aziz Bousfiha; Caroline Deswarte; Carmen Oleaga-Quintas; Jean-Laurent Casanova; Jacinta Bustamante; Adrian Liston
Journal:  J Allergy Clin Immunol       Date:  2018-12-19       Impact factor: 10.793

2.  Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice.

Authors:  Sheena R Baratono; Niansheng Chu; Lee P Richman; Edward M Behrens
Journal:  Eur J Immunol       Date:  2015-02-26       Impact factor: 5.532

3.  ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.

Authors:  Julia E Rood; Sheila Rao; Michele Paessler; Portia A Kreiger; Niansheng Chu; Erietta Stelekati; E John Wherry; Edward M Behrens
Journal:  Blood       Date:  2015-10-30       Impact factor: 22.113

4.  Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Authors:  Edward M Behrens; Scott W Canna; Katharine Slade; Sheila Rao; Portia A Kreiger; Michele Paessler; Taku Kambayashi; Gary A Koretzky
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

Review 5.  Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward.

Authors:  Rebecca A Marsh; Michael B Jordan; Alexandra H Filipovich
Journal:  Br J Haematol       Date:  2011-06-28       Impact factor: 6.998

6.  Genetic analysis of B-cell lymphomas associated with hemophagocytic lymphohistiocytosis.

Authors:  Kruti Patel; Sophia S Lee; Poojitha Valasareddy; Namratha R Vontela; Philippe Prouet; Mike G Martin
Journal:  Blood Adv       Date:  2016-12-14

7.  Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.

Authors:  Thomas N Burn; Lehn Weaver; Julia E Rood; Niansheng Chu; Aaron Bodansky; Portia A Kreiger; Edward M Behrens
Journal:  Arthritis Rheumatol       Date:  2019-12-15       Impact factor: 10.995

Review 8.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

9.  Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation.

Authors:  Cristina Dias; Allison McDonald; Murat Sincan; Rosemarie Rupps; Thomas Markello; Ramona Salvarinova; Rui F Santos; Kamal Menghrajani; Chidi Ahaghotu; Darren P Sutherland; Edgardo S Fortuno; Tobias R Kollmann; Michelle Demos; Jan M Friedman; David P Speert; William A Gahl; Cornelius F Boerkoel
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 10.  Genetic defects in cytolysis in macrophage activation syndrome.

Authors:  Mingce Zhang; Edward M Behrens; T Prescott Atkinson; Bita Shakoory; Alexei A Grom; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.